Skip to main content
Guerbet logo

Guerbet — Investor Relations & Filings

Ticker · GBT ISIN · FR0000032526 LEI · 969500WV1U1WQ059L135 PA Manufacturing
Open in API
Filings indexed 623 across all filing types
Latest filing 2025-03-18 Regulatory Filings
Country FR France
Listing PA GBT

About Guerbet

https://www.guerbet.com

Guerbet is a global specialist in medical imaging, offering a comprehensive range of solutions and services for diagnostic and interventional procedures. The company develops and manufactures contrast media, medical devices such as injectors, and related software for X-ray, Magnetic Resonance Imaging (MRI), and Interventional Imaging. With a history of innovation dating back to 1926, Guerbet focuses on providing healthcare professionals with tools to enhance diagnostic accuracy and improve patient care. Its portfolio is designed to support a wide array of clinical applications, from initial diagnosis to treatment monitoring.

Recent filings

Filing Released Lang Actions
DUOncoTM Bone : First CE marked IA algorithm for automatic detection of bone lesions on CT scan.
Regulatory Filings Classification · 100% confidence The document is a press release dated March 18, 2025, announcing that Intrasense and Guerbet have received CE marking under MDR for their AI solution, DUOnco™ Bone, for detecting bone lesions on CT scans. It details the product's features, clinical impact, and strategic positioning. This type of announcement, which is a general corporate update regarding a product/regulatory milestone but is not a formal financial report (like 10-K, IR, ER) or a specific regulatory filing (like DIRS, DIV), fits best under the general 'Regulatory Filings' or 'Report Publication Announcement' category if it were announcing a report. Since this is a product/regulatory milestone announcement, and it doesn't fit the specific definitions for financial reports, management changes, or shareholder actions, it is best classified as a general Regulatory Filing (RNS) or potentially a Capital/Financing Update (CAP) if it were about fundraising, but here it is about a regulatory approval (CE Mark). Given the options, RNS serves as the best general regulatory/corporate announcement fallback for non-standard filings. However, since it is a detailed announcement of a significant corporate/product development, and not just a brief notice, RNS is the most appropriate general category for this type of press release that doesn't fit the other specific financial or corporate action codes.
2025-03-18 English
GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 28 février 2025
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled "DECLARATION RELATIVE AU NOMBRE DE DROITS DE VOTE ET D'ACTIONS COMPOSANT LE CAPITAL DE LA SOCIETE" (Declaration relative to the number of voting rights and shares comprising the company's capital). It explicitly references French regulatory articles (Code de commerce, AMF regulations) and provides a monthly update (as of February 28, 2025) detailing the total number of shares, treasury shares, and total voting rights. This content directly corresponds to the definition of a Declaration of Voting Results & Voting Rights Announcement, which is categorized as 'DVA' in the provided schema.
2025-03-13 French
GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 31 janvier 2025
Regulatory Filings Classification · 95% confidence The document is a monthly disclosure required by the AMF (French Financial Markets Authority) regarding the total number of voting rights and shares composing the company's capital. This type of regulatory disclosure, which tracks changes in share capital and voting rights, falls under the category of general regulatory announcements or specific share capital updates. Given the specific nature of reporting total shares and voting rights as per Article L. 233-8 II of the French Commercial Code, it is best classified as a Regulatory Filing (RNS).
2025-02-21 French
GUERBET : 2024 revenue.
Earnings Release Classification · 100% confidence The document is a press release from Guerbet announcing its full-year 2024 revenue figures. It provides key financial highlights, revenue breakdowns by geography and activity, and forward-looking commentary on profitability and cash flow. It is not the full annual report (10-K) but rather the initial announcement of financial results, which fits the definition of an Earnings Release (ER). FY 2024
2025-02-06 English
GUERBET : Chiffre d’affaires 2024.
Earnings Release Classification · 100% confidence The document is a press release from Guerbet titled 'Chiffre d'affaires 2024' (2024 Revenue). It provides key financial highlights, including annual revenue figures, geographic breakdowns, and business segment performance for the fiscal year 2024. It explicitly states that the full annual results will be published on March 26, 2025. Because this document is an initial announcement of financial results (key highlights only) rather than the full audited annual report, it is classified as an Earnings Release. FY 2024
2025-02-06 French
GUERBET : Implementation of a Liquidity Contract with NATIXIS ODDO BHF
Regulatory Filings Classification · 90% confidence The document is a press release announcing the implementation of a liquidity contract for the company's shares with NATIXIS and ODDO BHF. A liquidity contract is a financial arrangement where a service provider trades in the company's shares to ensure market liquidity. This falls under the category of capital structure and share trading management. Among the provided categories, 'Regulatory Filings' (RNS) is the most appropriate fallback for this type of corporate announcement, as it does not involve a direct share buyback (POS), a new share issue (SHA), or a major shareholding notification (MRQ).
2025-02-03 English

Browse filings by year

19 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.